Nikko Asset Management Americas Inc. boosted its position in Absci Co. (NASDAQ:ABSI – Free Report) by 28.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,143,829 shares of the company’s stock after acquiring an additional 253,985 shares during the quarter. Nikko Asset Management Americas Inc.’s holdings in Absci were worth $2,997,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of the business. Sumitomo Mitsui Trust Group Inc. boosted its stake in Absci by 28.5% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,143,829 shares of the company’s stock valued at $2,997,000 after acquiring an additional 253,985 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Absci by 14.9% during the third quarter. JPMorgan Chase & Co. now owns 49,379 shares of the company’s stock worth $189,000 after purchasing an additional 6,409 shares during the period. SG Americas Securities LLC bought a new position in shares of Absci in the 4th quarter worth about $111,000. ARK Investment Management LLC boosted its holdings in shares of Absci by 30.4% in the 4th quarter. ARK Investment Management LLC now owns 8,265,936 shares of the company’s stock valued at $21,657,000 after buying an additional 1,928,314 shares during the period. Finally, Barclays PLC grew its position in shares of Absci by 379.6% during the 3rd quarter. Barclays PLC now owns 131,504 shares of the company’s stock valued at $503,000 after buying an additional 104,083 shares during the last quarter. 52.05% of the stock is currently owned by institutional investors and hedge funds.
Absci Stock Performance
ABSI stock opened at $3.21 on Tuesday. The company has a market capitalization of $368.69 million, a P/E ratio of -3.45 and a beta of 2.09. The company has a quick ratio of 5.63, a current ratio of 5.63 and a debt-to-equity ratio of 0.01. The company has a 50-day simple moving average of $3.87 and a 200 day simple moving average of $3.69. Absci Co. has a fifty-two week low of $2.45 and a fifty-two week high of $6.72.
Wall Street Analysts Forecast Growth
View Our Latest Stock Report on Absci
Absci Company Profile
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit.
Read More
- Five stocks we like better than Absci
- Breakout Stocks: What They Are and How to Identify Them
- Can TikTok Stock Picks Really Make You Rich?
- Why Invest in High-Yield Dividend Stocks?
- The “Quality” Rotation: Back to Basics Investing
- Earnings Per Share Calculator: How to Calculate EPS
- Occidental Petroleum: 4 Reasons to Love These Prices
Want to see what other hedge funds are holding ABSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Absci Co. (NASDAQ:ABSI – Free Report).
Receive News & Ratings for Absci Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Absci and related companies with MarketBeat.com's FREE daily email newsletter.